Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,3709634,systemic availability,"The systemic availability of methysergide was only 13%, most probably due to a high degree of first-pass metabolism to methylergometrine.",Pharmacokinetics of methysergide and its metabolite methylergometrine in man. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3709634/),%,13,80245,DB00247,Methysergide
,3709634,elimination half-life,Methylergometrine had a significantly longer elimination half-life than methysergide (223 +/- 43 min vs 62.0 +/- 8.3 min and 174 +/- 35 min vs 44.8 +/- 8.1 min in the oral and intravenous studies respectively).,Pharmacokinetics of methysergide and its metabolite methylergometrine in man. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3709634/),min,223,80246,DB00247,Methysergide
,3709634,elimination half-life,Methylergometrine had a significantly longer elimination half-life than methysergide (223 +/- 43 min vs 62.0 +/- 8.3 min and 174 +/- 35 min vs 44.8 +/- 8.1 min in the oral and intravenous studies respectively).,Pharmacokinetics of methysergide and its metabolite methylergometrine in man. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3709634/),min,62.0,80247,DB00247,Methysergide
,3709634,elimination half-life,Methylergometrine had a significantly longer elimination half-life than methysergide (223 +/- 43 min vs 62.0 +/- 8.3 min and 174 +/- 35 min vs 44.8 +/- 8.1 min in the oral and intravenous studies respectively).,Pharmacokinetics of methysergide and its metabolite methylergometrine in man. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3709634/),min,174,80248,DB00247,Methysergide
,3709634,elimination half-life,Methylergometrine had a significantly longer elimination half-life than methysergide (223 +/- 43 min vs 62.0 +/- 8.3 min and 174 +/- 35 min vs 44.8 +/- 8.1 min in the oral and intravenous studies respectively).,Pharmacokinetics of methysergide and its metabolite methylergometrine in man. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3709634/),min,44.8,80249,DB00247,Methysergide
,1974196,plasma clearance,The plasma clearance of MS was high and ranged from 74.2-102 ml/min per kg.,Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1974196/),[ml] / [kg·min],74.2-102,99990,DB00247,Methysergide
,1974196,formation clearance,"The formation of MEM after MS administration was relatively low and appeared to be saturable since the formation clearance of MEM decreased significantly from 3.5 to 1.9 ml/min per kg for the low and the high rate of iv infusion of MS, respectively.",Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat. ,CLint -Q3,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1974196/),[ml] / [kg·min],3.5,99991,DB00247,Methysergide
,1974196,formation clearance,"The formation of MEM after MS administration was relatively low and appeared to be saturable since the formation clearance of MEM decreased significantly from 3.5 to 1.9 ml/min per kg for the low and the high rate of iv infusion of MS, respectively.",Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat. ,CLint -Q3,[Article Link](https://pubmed.ncbi.nlm.nih.gov/1974196/),[ml] / [kg·min],1.9,99992,DB00247,Methysergide
